{"id":27993,"date":"2014-08-12T09:52:41","date_gmt":"2014-08-12T13:52:41","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=27993"},"modified":"2014-08-12T09:52:41","modified_gmt":"2014-08-12T13:52:41","slug":"wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993","title":{"rendered":"Wells Fargo &#038; Co (NYSE:WFC) Leads Upgrading Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Shares"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 08\/12\/2014 (wallstreetpr) \u2013 Biopharmaceutical company, <b>Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)<\/b> got the attention of at least three brokerages, namely, <b>Wells Fargo &amp; Co (NYSE:WFC),<\/b> Piper Jaffray and JMP Securities. They have also resorted to lifting their price objective on the stock after the company delivered better than estimated earnings number. The equity analysts\u2019 move comes after the company announced its quarterly numbers on August 7.<\/p>\n<p style=\"text-align: justify;\"><b>Rating Of Stock<\/b><\/p>\n<p style=\"text-align: justify;\">Investment advisor Wells Fargo &amp; Co (NYSE:WFC)\u00a0had upgraded the shares of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)\u00a0to <a href=\"http:\/\/www.streetinsider.com\/Analyst+Comments\/Wells+Fargo+Upgrades+Achillion+Pharmaceuticals+(ACHN)+to+Outperform\/9738579.html\">Outperform<\/a> rating on Monday from Market Perform rating. The brokerage felt compelled to lift the price objective too. As a result, it had lifted its price target on the shares of Achillion Pharmaceuticals to $11 &#8211; $13 from $7 &#8211; $8 projected earlier by it.<\/p>\n<p style=\"text-align: justify;\">Wells Fargo analyst Brian Abraham was more confident about the progress of ACH-3422 without incident. He was even more optimistic about 3422 and 3102 readouts. The revised price target meant that the stock is poised to move upwards by over 50% based on the price of $7.59.<\/p>\n<p style=\"text-align: justify;\">Another financial advisor Piper Jaffray had also upgraded the shares of Achillion Pharmaceuticals to <a href=\"http:\/\/www.benzinga.com\/analyst-ratings\/upgrades\/14\/08\/4770380\/piper-jaffray-upgrades-achillion-pharmaceuticals-to-overweigh\">Overweight<\/a> rating on Monday from Neutral. The brokerage had also boosted its price target to $10 from $5 on the company\u2019s stock. It suggests that a maximum of around 31% upside potential is possible.<\/p>\n<p style=\"text-align: justify;\">One more financial analyst, JMP Securities too joined the party to lift the rating to Outperform from Market perform on Friday. They have also boosted the price objective to $13, which indicates a potential upside reward of nearly 70%.<\/p>\n<p style=\"text-align: justify;\"><b>Technical Data<\/b><\/p>\n<p style=\"text-align: justify;\">Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)\u00a0had hit a yearly <a href=\"http:\/\/finance.yahoo.com\/q\/ks?s=ACHN+Key+Statistics\">high<\/a> price of $8.61 and a low $2.26. The stock also had a 50-day and 200-day moving average prices of $7.25 and $2.26 respectively. Given the recent quarterly earnings results and the resultant upgrades by different brokerages and boosting of price target, the stock could likely hit a fresh high in the coming months. However, the chances of the stock breaking the 52-week low look dim in the current situation.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 08\/12\/2014 (wallstreetpr) \u2013 Biopharmaceutical company, Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) got the attention of at least three brokerages, namely, Wells Fargo &amp; Co (NYSE:WFC), [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":25320,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[2990,2991,1012,1866],"stock_ticker":[],"class_list":["post-27993","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-achillion-pharmaceuticals-inc-nasdaqachn","tag-nasdaqachn","tag-nysewfc","tag-wells-fargo-co-nysewfc","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Wells Fargo &amp; Co (NYSE:WFC) Leads Upgrading Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Shares - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Wells Fargo &amp; Co (NYSE:WFC) Leads Upgrading Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Shares - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 08\/12\/2014 (wallstreetpr) \u2013 Biopharmaceutical company, Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) got the attention of at least three brokerages, namely, Wells Fargo &amp; Co (NYSE:WFC), [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-08-12T13:52:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Achillion-Pharmaceuticals-Inc..jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"259\" \/>\n\t<meta property=\"og:image:height\" content=\"194\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Wells Fargo &#038; Co (NYSE:WFC) Leads Upgrading Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Shares\",\"datePublished\":\"2014-08-12T13:52:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993\"},\"wordCount\":344,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Achillion-Pharmaceuticals-Inc..jpg\",\"keywords\":[\"Achillion Pharmaceuticals Inc (NASDAQ:ACHN)\",\"NASDAQ:ACHN\",\"NYSE:WFC\",\"Wells Fargo &amp; Co (NYSE:WFC)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993\",\"name\":\"Wells Fargo & Co (NYSE:WFC) Leads Upgrading Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Shares - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Achillion-Pharmaceuticals-Inc..jpg\",\"datePublished\":\"2014-08-12T13:52:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Achillion-Pharmaceuticals-Inc..jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Achillion-Pharmaceuticals-Inc..jpg\",\"width\":259,\"height\":194},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Wells Fargo &#038; Co (NYSE:WFC) Leads Upgrading Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Shares\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Wells Fargo & Co (NYSE:WFC) Leads Upgrading Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Shares - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993","og_locale":"en_US","og_type":"article","og_title":"Wells Fargo & Co (NYSE:WFC) Leads Upgrading Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Shares - Wall Street PR","og_description":"Boston, MA 08\/12\/2014 (wallstreetpr) \u2013 Biopharmaceutical company, Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) got the attention of at least three brokerages, namely, Wells Fargo &amp; Co (NYSE:WFC), [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-08-12T13:52:41+00:00","og_image":[{"width":259,"height":194,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Achillion-Pharmaceuticals-Inc..jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Wells Fargo &#038; Co (NYSE:WFC) Leads Upgrading Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Shares","datePublished":"2014-08-12T13:52:41+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993"},"wordCount":344,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Achillion-Pharmaceuticals-Inc..jpg","keywords":["Achillion Pharmaceuticals Inc (NASDAQ:ACHN)","NASDAQ:ACHN","NYSE:WFC","Wells Fargo &amp; Co (NYSE:WFC)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993","name":"Wells Fargo & Co (NYSE:WFC) Leads Upgrading Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Shares - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Achillion-Pharmaceuticals-Inc..jpg","datePublished":"2014-08-12T13:52:41+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Achillion-Pharmaceuticals-Inc..jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Achillion-Pharmaceuticals-Inc..jpg","width":259,"height":194},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/wells-fargo-co-nysewfc-leads-upgrading-achillion-pharmaceuticals-inc-nasdaqachn-shares-27993#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Wells Fargo &#038; Co (NYSE:WFC) Leads Upgrading Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Shares"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/27993","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=27993"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/27993\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/25320"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=27993"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=27993"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=27993"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=27993"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}